Dopamine HCl Injection Recall: Pfizer 200 mg/5 mL
Announced 2026-09-23 · FDA
Pfizer Dopamine HCl Injection, 200 mg/5 mL, 5 mL single-dose vials (25 per tray) Rx only, distributed by Hospira, Inc., Lake Forest, IL, is being recalled. The recall is due to lack of assurance of sterility for Lot NL5230 (Exp 10/2027) distributed nationwide in the United States.
| Brand | Pfizer |
|---|---|
| Product | Dopamine HCl Inj., USP, 200 mg/5 mL (40 mg/mL), 5 mL Single-dose, 25 vials per tray, Rx only, Distributed by Hospira, Inc., Lake Forest, IL 60045 USA, Vial NDC 0409-5820-11, Carton NDC 0409-5820-01. |
| Reason | Lack of Assurance of Sterility |
| Severity | moderate |
| Units affected | N/A |
| Distribution | US Nationwide. |
| Agency | FDA |
WHAT YOU SHOULD DO
- Do not use or administer any vials from Lot NL5230.
- Contact the hospital, clinic, or pharmacy that dispensed the product for instructions on return, replacement, or disposal.
- If you are prescribed this product, talk to your prescriber about alternatives or a replacement.
- If you have concerns about health effects, contact your healthcare professional for advice.
How to identify the recalled item
| Lot / date codes | Lot # NL5230, Exp Date:10/2027 |
|---|---|
| Lot / date codes | Lot # NL5230, Exp Date:10/2027 |
These are the identifiers FDA published for this recall. Most recall notices list no UPC or model number at all — if the code on your item is not shown here, that does not mean the item is excluded. Check the official notice, or contact the company.
This is an automatically maintained record of an official recall notice. Details can change; always follow the official notice linked above. See all records in the Recall Database.